In addition to development of the combined in vitro/in vivo screening assay, we also deployed array tomography to detect AβO distribution and binding localization with specific synaptic elements at extremely high spatial resolution, using AβO-selective labeling with 3B3 in APP/PS1 Tg mouse and human AD brain tissue sections. The gene discussed is ABO; the disease is Alzheimer disease.